Position in GNLX
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$22,939
-$18,389 QoQ
Shares Held
9,479
0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Blue Trust, Inc. holds $4,223,492 across 69 Biotechnology names. GNLX ranks #22 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
15,939 | $683,623 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
772 | $596,478 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
3,003 | $567,716 | |
| 4 | DMAC |
DiaMedica Therapeutics Inc.
|
69,122 | $467,955 | |
| 5 | GMAB |
Genmab A/S
|
11,609 | $311,468 | |
| 6 | ACHV |
Achieve Life Sciences, Inc.
|
85,888 | $252,510 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
826 | $245,296 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
425 | $189,779 |
All Filings in GNLX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,939 | 9,479 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $41,328 | 9,479 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $42,718 | 10,171 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $29,190 | 10,171 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $27,461 | 10,171 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $24,003 | 10,171 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $23,472 | 9,904 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $19,312 | 9,904 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $63,682 | 9,904 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $129,410 | 9,237 | Shares | Sole | 2024-01-18 | |
| No filing history on record for this holder in this stock. | ||||||